MPM
ELV icon

Meritage Portfolio Management’s Elevance Health ELV Stock Holding History

Meritage Portfolio Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$382K Sell
1,090
-77
-7% -$26K 0.03% 249
2025
Q3 		$377K Sell
1,167
-19
-2% -$5.91K 0.03% 257
2025
Q2 		$461K Hold
1,186
– – 0.03% 253
2025
Q1 		$516K Sell
1,186
-93
-7% -$37.3K 0.03% 236
2024
Q4 		$472K Sell
1,279
-10,237
-89% -$4.28M 0.03% 255
2024
Q3 		$5.99M Sell
11,516
-269
-2% -$144K 0.37% 77
2024
Q2 		$6.39M Sell
11,785
-139
-1% -$73.5K 0.4% 67
2024
Q1 		$6.18M Sell
11,924
-754
-6% -$375K 0.39% 76
2023
Q4 		$5.98M Buy
12,678
+478
+4% +$221K 0.39% 75
2023
Q3 		$5.31M Sell
12,200
-373
-3% -$169K 0.39% 84
2023
Q2 		$5.59M Sell
12,573
-753
-6% -$347K 0.4% 84
2023
Q1 		$6.13M Buy
13,326
+30
+0.2% +$14.3K 0.46% 72
2022
Q4 		$6.82M Sell
13,296
-174
-1% -$88.3K 0.53% 58
2022
Q3 		$6.12M Sell
13,470
-468
-3% -$224K 0.51% 57
2022
Q2 		$6.73M Buy
13,938
+245
+2% +$121K 0.52% 57
2022
Q1 		$6.73M Buy
13,693
+510
+4% +$233K 0.42% 71
2021
Q4 		$6.11M Sell
13,183
-249
-2% -$105K 0.35% 85
2021
Q3 		$5.01M Buy
+13,432
New +$5.1M 0.3% 97
2020
Q1 		– Sell
-9,331
Closed -$2.82M – 199
2019
Q4 		$2.82M Sell
9,331
-356
-4% -$98K 0.25% 144
2019
Q3 		$2.33M Buy
9,687
+7,354
+315% +$2.01M 0.22% 155
2019
Q2 		$658K Buy
+2,333
New +$637K 0.07% 164
2019
Q1 		– Sell
-18,131
Closed -$4.76M – 188
2018
Q4 		$4.76M Sell
18,131
-493
-3% -$136K 0.54% 66
2018
Q3 		$5.1M Sell
18,624
-245
-1% -$63.6K 0.47% 93
2018
Q2 		$4.49M Sell
18,869
-626
-3% -$145K 0.44% 102
2018
Q1 		$4.28M Buy
+19,495
New +$4.58M 0.41% 104

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Meritage Portfolio Management's ELV Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Elevance Health (ELV) stake by 6.6% in Q4 2025, selling an estimated $26K and leaving 1,090 shares worth $382K. The position accounts for 0.03% of the portfolio, ranked #249.

Meritage Portfolio Management first reported a position in ELV in Q1 2018 and has held it in 25 quarters since. The position peaked at $6.82M in Q4 2022. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Meritage Portfolio Management held 1,090 shares of Elevance Health worth $382K as of Q4 2025.
  • Meritage Portfolio Management sold 77 Elevance Health shares in Q4 2025, an estimated $26K.
  • Elevance Health made up 0.03% of Meritage Portfolio Management's portfolio in Q4 2025, its #249 holding.
  • Meritage Portfolio Management first reported a position in Elevance Health in Q1 2018 and has held it in 25 quarters since.
  • Meritage Portfolio Management's Elevance Health position peaked at $6.82M in Q4 2022.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.